San Francisco, CA-based Proximal Ventures closed a $27.5M fund to back pre-seed and seed AI-native companies across the pharmaceutical value chain, including computational drug discovery, clinical development, manufacturing, and commercialization.
11/13/2026
Zacua Ventures Fund II
San Francisco, CA, USA-based Zacua Ventures closed $135M Fund II to invest...

